ES2057101T3 - Agente terapeutico para las enfermedades del higado y derivados de la piperazina. - Google Patents

Agente terapeutico para las enfermedades del higado y derivados de la piperazina.

Info

Publication number
ES2057101T3
ES2057101T3 ES89300743T ES89300743T ES2057101T3 ES 2057101 T3 ES2057101 T3 ES 2057101T3 ES 89300743 T ES89300743 T ES 89300743T ES 89300743 T ES89300743 T ES 89300743T ES 2057101 T3 ES2057101 T3 ES 2057101T3
Authority
ES
Spain
Prior art keywords
group
alkyl
therapeutic agent
aralkyl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89300743T
Other languages
English (en)
Inventor
Mitsuo Masaki
Tomio Yamakawa
Masaru Satoh
Hiromitsu Takeda
Yasushi Yoshino
Hitoshi Matsukura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Chemiphar Co Ltd
Original Assignee
Nippon Chemiphar Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co Ltd filed Critical Nippon Chemiphar Co Ltd
Application granted granted Critical
Publication of ES2057101T3 publication Critical patent/ES2057101T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/21—Radicals derived from sulfur analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02M—SUPPLYING COMBUSTION ENGINES IN GENERAL WITH COMBUSTIBLE MIXTURES OR CONSTITUENTS THEREOF
    • F02M11/00—Multi-stage carburettors, Register-type carburettors, i.e. with slidable or rotatable throttling valves in which a plurality of fuel nozzles, other than only an idling nozzle and a main one, are sequentially exposed to air stream by throttling valve

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Combustion & Propulsion (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A UN AGENTE TERAPEUTICO PARA ENFERMEDADES DEL HIGADO QUE CONTIENE COMO INGREDIENTE ACTIVO UN DERIVADO DE PIPERAZINA DE FORMULA(I) EN LA QUE A ES UN GRUPO FENILO, P BENZOQUINONILO O CUMARINILO QUE PUEDE TENER AL MENOS UN SUSTITUYENTE SELECCIONADO DEL GRUPO FORMADO POR HALOGENO, ALQUILO, FLUOROALQUILO, FORMILO, MERCAPTO, ALQUILTIO Y NITRO; B ES UN ENLACE SENCILLO O UN GRUPO ALQUILENO DE CADENA RECTA CONTENIENDO DE 1 A 4 C QUE PUEDEN TENER POR LO MENOS UN SUSTITUYENTE SELECCIONADO DEL GRUPO FORMADO POR ALQUILO, ARILO, ARALQUILO, HIDROXI Y OXO; R ES UN ATOMO O GRUPO SELECCIONADO DEL GRUPO FORMADO POR H, METAL ALCALINO O ALCALINOTERREO, ALQUILO CICLOALQUILO, ARALQUILO, Y ARILO, Y N ES 2 O 3, O A UNA SAL SUYA ACEPTABLE PARA EMPLEO FARMACEUTICO.
ES89300743T 1988-01-26 1989-01-26 Agente terapeutico para las enfermedades del higado y derivados de la piperazina. Expired - Lifetime ES2057101T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP1362288 1988-01-26
JP8446188 1988-04-05
JP8446088 1988-04-05
JP8445988 1988-04-05

Publications (1)

Publication Number Publication Date
ES2057101T3 true ES2057101T3 (es) 1994-10-16

Family

ID=27456040

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89300743T Expired - Lifetime ES2057101T3 (es) 1988-01-26 1989-01-26 Agente terapeutico para las enfermedades del higado y derivados de la piperazina.

Country Status (8)

Country Link
US (2) US5070089A (es)
EP (1) EP0326379B1 (es)
KR (1) KR890011868A (es)
AT (1) ATE106398T1 (es)
AU (1) AU609933B2 (es)
CA (1) CA1326451C (es)
DE (1) DE68915555T2 (es)
ES (1) ES2057101T3 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9004348D0 (en) * 1990-02-27 1990-04-25 Orion Yhtymae Oy New use of catechol derivatives and their physiologically acceptable salts and esters
US5489614A (en) * 1987-11-27 1996-02-06 Orion-Yhtyma Oy Catechol derivatives, their physiologically acceptable salts, esters and use
KR890011868A (ko) * 1988-01-26 1989-08-23 원본미기재 간질환 치료제 및 피페라진 유도체
HU214331B (hu) * 1992-06-17 1998-03-02 Gyógyszerkutató Intézet Kft. Eljárás piperazin- és homopiperazinszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
FR2703048B1 (fr) * 1993-03-24 1996-01-05 Adir Nouveaux composes n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2757164B1 (fr) * 1996-12-16 1999-01-22 Adir Nouveaux derives de n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN1157388C (zh) * 2001-05-29 2004-07-14 北京大学 哌嗪基二硫代甲酸酯类化合物,它们的制备方法和在抗肿瘤药物中的应用
US20110190749A1 (en) * 2008-11-24 2011-08-04 Mcmillan Kathleen Low Profile Apparatus and Method for Phototherapy
EP3235815A1 (de) * 2016-04-19 2017-10-25 Philipps-Universität Marburg Wirkstoffe gegen parasitäre helminthen

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3449360A (en) * 1965-02-17 1969-06-10 Ciba Geigy Corp Dithioacid esters
US3740430A (en) * 1967-12-14 1973-06-19 Astra Ab Method for inhibiting dopamine-beta-hydroxylase using piperazine derivatives of dithiocarboxylates,and pharmaceutical preparations thereof
NO125185B (es) * 1967-12-14 1972-07-31 Astra Ab
GB1261345A (en) * 1968-03-07 1972-01-26 Ici Ltd Sulphur-containing benzyl derivatives and pesticidal compositions containing them
FR2081589A1 (en) * 1970-03-26 1971-12-10 Roussel Uclaf N,n-hexamethylenedithiocarbamates - as hepato protective agents
US4076814A (en) * 1975-06-09 1978-02-28 Sankyo Company Limited Preventive and curative compositions against mycoplasmosis
DE2713586A1 (de) * 1976-04-09 1977-10-20 Sandoz Ag Neue organische verbindungen, verfahren zu ihrer herstellung und ihre verwendung
SE8304361D0 (sv) * 1983-08-10 1983-08-10 Ferrosan Ab Novel 1-acylpiperazine derivatives novel 1-acylpiperazine derivatives
KR890011868A (ko) * 1988-01-26 1989-08-23 원본미기재 간질환 치료제 및 피페라진 유도체

Also Published As

Publication number Publication date
KR890011868A (ko) 1989-08-23
US5070089A (en) 1991-12-03
EP0326379B1 (en) 1994-06-01
AU609933B2 (en) 1991-05-09
AU2887089A (en) 1989-07-27
CA1326451C (en) 1994-01-25
EP0326379A2 (en) 1989-08-02
EP0326379A3 (en) 1991-01-09
DE68915555T2 (de) 1994-10-20
US5446146A (en) 1995-08-29
ATE106398T1 (de) 1994-06-15
DE68915555D1 (de) 1994-07-07

Similar Documents

Publication Publication Date Title
ES2141137T3 (es) Agentes terapeuticos para la enfermedad de parkinson.
LU91210I2 (fr) Emodepside & Praziquantel ainsi que leurs dérivés pharmaceutiqement acceptables (PROFENDER)
LU91832I2 (fr) Fingolimod et ses dérivés pharmaceutiquement acceptables (GILENYA®)
FI950309A (fi) Proliiniamidijohdannaisia
FI904602A0 (fi) Pyrazoloderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
ES2057101T3 (es) Agente terapeutico para las enfermedades del higado y derivados de la piperazina.
DK0570294T3 (da) 2-formylpyridinthiosemicarbazonderivater, deres fremstilling og deres anvendelse som antitumormiddel
ATE223411T1 (de) 1-methylcarbapenem-derivate
FI884070A (fi) Rytmstoerningar foerhindrande medel.
DE3862791D1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
ATE126213T1 (de) Pyrrolaldehydderivate.
ES2141134T3 (es) Derivados de carbamoil pirrolidona para el tratamiento de la depresion y de los trastornos cerebrovasculares.
SE8200679L (sv) 1-bensyl-4-(4-(2-pyrimidinylamino) bensyl 1-2,3-dioxopiperazinderivat, salter derav, forfarande for framstellning derav och karcinostatiska medel der de ingar
EP0919233A4 (en) THERAPEUTIC AGENT FOR KIDNEY DISEASE
ATE157874T1 (de) Mittel zur verbesserung der peripheren durchblutung
DK653687A (da) Middel til behandling af nyresygdomme

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 326379

Country of ref document: ES